Recent Quotes (30 days)

You have no recent quotes
chg | %

SQI Diagnostics Inc.  

(Public, CVE:SQD)   Watch this stock  
Find more results for SQD
0.315
0.000 (0.00%)
Jun 17 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.24 - 0.50
Open     -
Vol / Avg. 0.00/1,776.00
Mkt cap 18.11M
P/E     -
Div/yield     -
EPS -0.09
Shares 69.35M
Beta 1.57
Inst. own     -
Aug 16, 2016
Q3 2016 SQI Diagnostics Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
May 13, 2016
Q2 2016 SQI Diagnostics Inc Earnings Release
May 13, 2016
Q2 2016 SQI Diagnostics Inc Earnings Call - Webcast
  

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin -352.50% -1376.30%
Operating margin -353.93% -1378.78%
EBITD margin - -1166.37%
Return on average assets -66.40% -131.16%
Return on average equity -131.15% -204.36%
Employees 33 -
CDP Score - -

Address

36 Meteor Dr
ETOBICOKE, ON M9W 1A4
Canada
+1-416-6749500 (Phone)
+1-416-6749300 (Fax)

Website links

Description

SQI Diagnostics Inc. is a Canada-based life sciences company that develops and commercializes technologies and products for multiplexing diagnostics. The Company provides technology and equipment for blood testing in clinical trials and pre-clinical research for pharmaceutical and biotechnology companies. The Company applies its multiplexing technology to diagnostic tests used for customers in the animal health market, which includes companion and production animal tests for infectious diseases, food safety and other immunology tests. The Company also offers solutions for human diagnostic testing. The Company is also working on a pipeline of multiplexed in vitro diagnostics (IVD) products, which target protein and antibody biomarkers relevant to autoimmune and other immunological diseases. It offers detecting and quantifying proteins, antibodies and deoxyribonucleic acid (DNA). It offers assay development solutions. It offers sqidworks, sqidlite and sqid-X technologies.

Officers and directors

Andrew Morris President, Chief Executive Officer, Director
Patricia Lie Chief Financial Officer, Vice President of Finance and Administration
Catherine Smith Vice President - Technology
Jaymie R. Sawyer Vice President - Research & Development
Peter D. Winkley Chairman of the Board
Clive J. Beddoe Director
Age: 68
Gerald R. Connor Director
Age: 70
Wilmot L. Matthews Director
Age: 77
Cameron R. Prange Director
Allan Pronovost Ph.D. Director
Age: 56